| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2021 | Jun 7, 2021 | Revolution Medicines, Inc. | 10% Owner | Sell | 15.0 | -543,113 | -8.93% | ✗ | $16.4M |
| May 25, 2021 | May 27, 2021 | Revolution Medicines, Inc. | 10% Owner | Sell | 15.0 | -1,366,204 | -17.47% | ✗ | $41.8M |
| Jan 12, 2021 | Jan 14, 2021 | Relay Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -5,622,394 | -42.08% | ✗ | $227.1M |
| Jul 22, 2019 | Jul 22, 2019 | Fulcrum Therapeutics, Inc. | Director | Buy | 87.5 | +81,250 | 1.38% | ✗ | $1.3M |
| Mar 23, 2017 | Mar 27, 2017 | CytomX Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -1,650,000 | -24.19% | ✗ | $28.7M |